PSNPrescribable
riociguat 0.5 MG Oral Tablet
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
Adempas Tablet, Film Coated
RxNorm Crosswalk NDC 50419-254
View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC
RxNorm Mapping Clinical Concepts
This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
The product Adempas (NDC 50419-254) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 10 unique RxNorm concepts. By anchoring Bayer Healthcare Pharmaceuticals Inc.'s product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.
The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).
SCDPrescribable
Featured Concept
riociguat 0.5 MG Oral Tablet
(RxCUI 1439821)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
SCDPrescribable
Featured Concept
riociguat 1.5 MG Oral Tablet
(RxCUI 1439823)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
SCDPrescribable
Featured Concept
riociguat 1 MG Oral Tablet
(RxCUI 1439831)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
SCDPrescribable
Featured Concept
riociguat 2.5 MG Oral Tablet
(RxCUI 1439833)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
SCDPrescribable
Featured Concept
riociguat 2 MG Oral Tablet
(RxCUI 1439837)
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
PSNPrescribable
Featured Concept
Adempas 0.5 MG Oral Tablet
(RxCUI 1439894)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
PSNPrescribable
Featured Concept
Adempas 1 MG Oral Tablet
(RxCUI 1439896)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
PSNPrescribable
Featured Concept
Adempas 1.5 MG Oral Tablet
(RxCUI 1439899)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
PSNPrescribable
Featured Concept
Adempas 2 MG Oral Tablet
(RxCUI 1439901)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
PSNPrescribable
Featured Concept
Adempas 2.5 MG Oral Tablet
(RxCUI 1439903)
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
Understanding RxNorm Mapping for Adempas
RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 50419-254 to RxCUI 1439821, 1439823, 1439831, 1439833, 1439837, 1439894, 1439896, 1439899, 1439901, 1439903, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.
Term Type (TTY) Legend for This Page
The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:
- PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
- SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
- SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.
- SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
* Please review the full disclaimer at the bottom of this page.
